Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

SYDNEY, July 01, 2024 (GLOBE NEWSWIRE) -- IREN (Iris Energy Limited) (NASDAQ: IREN ) (together with its subsidiaries, "IREN" or “the Company”), a leading next-generation data center business powering the future of Bitcoin, AI and beyond, today provided a business update. ...

Stellantis to Announce First Half 2024 Results on July 25 AMSTERDAM, July 1, 2024 - Stellantis N.V. announced today that its First Half 2024 Results will be released on Thursday, July 25, 2024. A live webcast and conference call of the First Half 2024 Results will begin at 2:00 ...

First non-Bentley family member to lead company, Cumins unveils vision for infrastructure resilience powered by AI, focus on operations phase of lifecycle Following the CEO transition plan previously announced by Bentley Systems, Incorporated (Nasdaq: BSY), Nicholas Cumins today takes c...

Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex PR Newswire WASHINGTON , July 1, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. District Court for the District of ...

MEDIA ALERT: Equinix Sets Conference Call for Second-Quarter PR Newswire REDWOOD CITY, Calif. , July 1, 2024 /PRNewswire/ -- Equinix, Inc. (Nasdaq: EQIX), the world's digital infrastructure company ® , today announced that it will hold its quarterly ...

TURTLE CREEK, Pa., July 01, 2024 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), a leading provider of safe, scalable, efficient, and sustainable zinc-based long duration energy storage systems, today announced it successfully launched comme...

Platform’s strength in API-first, headless (MACH) architecture is recognized to deliver the critical functionalities, ease-of-use and flexibility large brands and retailers need to scale more efficiently, maintain high performance and create frictionless customer experiences Bi...

Drug-device combination leverages Biora’s NaviCap ™ platform to deliver tofacitinib directly to colonic tissue as a potential treatment for ulcerative colitis BT-600 was well tolerated and met all trial objectives, demonstrating the NaviCap platform’s ab...

CHASKA, Minn., July 01, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced it has reached a cooperation agreemen...

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic disease, today announced the closing of its previously announced $11.8 million private placement to accredited investors. The Company sold approximatel...